CD19/BCMA dual-targeted CAR-T cell therapy

· Second Affiliated Hospital, School of Medicine, Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19/BCMA dual-targeted CAR-T cell therapy, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma [NA]